DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q1 2020 13F-HR Holdings
Net value change ($000)
+16,898
(0.5%)
New positions
27
Sold out positions
16
Turnover %
33.4%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q4 2019
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| TOI | 103,031 | NEW |
| AHCO | 86,343 | 45.7% |
| SDGR | 58,047 | NEW |
| ABIOMED INC | 54,580 | NEW |
| PCRX | 54,571 | NEW |
| RVMD | 39,359 | NEW |
| NTRA | 39,296 | NEW |
| FOLD | 30,067 | NEW |
| MCK | 23,730 | NEW |
| BIODELIVERY SCIENCES INTERNATIONAL INC | 23,438 | NEW |
Top Reduces (Value $000, Stocks/ETFs)
| Ra Pharmaceuticals, Inc. | -71,320 | -100.0% |
| Orchard Therapeutics plc | -55,123 | -45.2% |
| TNDM | -54,582 | -67.3% |
| RYTM | -52,342 | -53.1% |
| QTTB | -45,845 | -42.2% |
| XLRN | -41,793 | -57.6% |
| MyoKardia, Inc. | -41,266 | -71.8% |
| Intersect ENT, Inc. | -36,961 | -53.1% |
| MIRM | -36,282 | -42.9% |
| ARDX | -35,040 | -66.7% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|